lifestyle.duovoltart.com

Author: Rivus Pharmaceuticals, Inc.

Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH

April 14, 2026
Rivus Pharmaceuticals Appoints Jorge Bartolome as Chief Executive Officer

February 25, 2026